Trials / Conditions / Cancer of the Bile Duct
Cancer of the Bile Duct
5 registered clinical trials studyying Cancer of the Bile Duct — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in NCT05849480 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Tempus Priority Study: A Pan-tumor Observational Study NCT05179824 | Tempus AI | — |
| Unknown | Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction NCT03821025 | University of Cape Town | N/A |
| Completed | Single Agent Regorafenib in Refractory Advanced Biliary Cancers NCT02115542 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Withdrawn | Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder NCT00386516 | Galectin Therapeutics Inc. | Phase 2 |